{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:10Z","timestamp":1786980490760,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10067-025-07748-7","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T11:23:13Z","timestamp":1760786593000},"page":"4797-4805","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["From endotypes to therapeutic targets: exploring the potential of precision treat-to-target approaches in primary Sj\u00f6gren\u2019s disease"],"prefix":"10.1007","volume":"44","author":[{"given":"Jiayang","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuebo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3904-8928","authenticated-orcid":false,"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,18]]},"reference":[{"issue":"9","key":"7748_CR1","doi-asserted-by":"publisher","first-page":"e636","DOI":"10.1016\/S2665-9913(24)00039-0","volume":"6","author":"S Gandolfo","year":"2024","unstructured":"Gandolfo S (2024) Precision medicine in Sj\u00f6gren\u2019s disease. Lancet Rheumatol 6(9):e636\u2013e647","journal-title":"Lancet Rheumatol"},{"key":"7748_CR2","doi-asserted-by":"publisher","unstructured":"He J et al (2025) Theory & practice of treat-to-target (T2T) in rheumatoid arthritis. Best Pract Res Clin Rheumatol. https:\/\/doi.org\/10.1016\/j.berh.2024.102018","DOI":"10.1016\/j.berh.2024.102018"},{"issue":"9","key":"7748_CR3","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/art.42238","volume":"74","author":"SS McCoy","year":"2022","unstructured":"McCoy S et al (2022) Symptom-based cluster analysis categorizes Sj\u00f6gren\u2019s disease subtypes: an international cohort study highlighting disease severity and treatment discordance. Arthritis Rheumatol 74(9):1569\u20131579","journal-title":"Arthritis Rheumatol"},{"key":"7748_CR4","doi-asserted-by":"crossref","unstructured":"Berry, J.S., et al (2024) Stability of symptom-based subtypes in Sj\u00f6gren\u2019s disease. Rmd Open, 10(4).","DOI":"10.1136\/rmdopen-2024-004914"},{"key":"7748_CR5","doi-asserted-by":"publisher","unstructured":"Nguyen Y et al (2025) Distinct Pathophysiologic\u00a0Pathways Support Stratification of Sj\u00f6gren\u2019s Disease Based on Symptoms, Clinical, and Routine Biological Data. Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/art.43096","DOI":"10.1002\/art.43096"},{"issue":"6","key":"7748_CR6","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s10067-025-07434-8","volume":"44","author":"X Qi","year":"2025","unstructured":"Qi X (2025) B lymphocyte subset-based stratification in primary Sj\u00f6gren\u2019s syndrome: implications for lymphoma risk and personalized treatment. Clin Rheumatol 44(6):2403\u20132412","journal-title":"Clin Rheumatol"},{"key":"7748_CR7","doi-asserted-by":"publisher","unstructured":"Lopes AP et al (2021) The transcriptomic profile of monocytes from patients with Sj\u00f6gren\u2019s syndrome is associated with inflammatory parameters and is mimicked by circulating mediators. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.701656","DOI":"10.3389\/fimmu.2021.701656"},{"key":"7748_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02535-6","author":"M Miao","year":"2021","unstructured":"Miao M et al (2021) Therapeutic potential of targeting Tfr\/Tfh cell balance by low-dose-IL-2 in active SLE: a post hoc analysis from a double-blind RCT study. Arthritis Res Ther. https:\/\/doi.org\/10.1186\/s13075-021-02535-6","journal-title":"Arthritis Res Ther"},{"issue":"20","key":"7748_CR9","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1097\/CM9.0000000000003275","volume":"137","author":"X Xiao","year":"2024","unstructured":"Xiao X et al (2024) Immune skew of follicular helper T cells and effector T cells in patients with Sj\u00f6gren\u2019s syndrome. Chin Med J 137(20):2518\u20132520","journal-title":"Chin Med J"},{"issue":"1","key":"7748_CR10","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/rheumatology\/keaa243","volume":"60","author":"XY Zhou","year":"2021","unstructured":"Zhou XY et al (2021) Immune responses after influenza vaccination in patients of primary Sj\u00f6gren\u2019s syndrome. Rheumatology 60(1):224\u2013230","journal-title":"Rheumatology"},{"key":"7748_CR11","doi-asserted-by":"publisher","unstructured":"Liang KL (2021) Sustained low-dose interleukin-2 therapy alleviates pathogenic humoral immunity via elevating the Tfr\/Tfh ratio in lupus. Clin Transl Immunol. https:\/\/doi.org\/10.1002\/cti2.1293","DOI":"10.1002\/cti2.1293"},{"issue":"1","key":"7748_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.scib.2022.12.024","volume":"68","author":"ZG Li","year":"2023","unstructured":"Li ZG, He J, Miao M (2023) Low-dose interleukin-2 therapy in autoimmune and inflammatory diseases: facts and hopes. Sci Bull 68(1):10\u201313","journal-title":"Sci Bull"},{"key":"7748_CR13","doi-asserted-by":"publisher","unstructured":"Ge F et al (2022) Evaluation of clinical and safety outcomes of neoadjuvant immunotherapy combined with chemotherapy for patients with resectable esophageal cancer. JAMA Netw Open. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.39778","DOI":"10.1001\/jamanetworkopen.2022.39778"},{"issue":"6","key":"7748_CR14","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.4049\/jimmunol.0803588","volume":"182","author":"L Le Pottier","year":"2009","unstructured":"Le Pottier L et al (2009) Ectopic germinal centers are rare in Sj\u00f6gren\u2019s syndrome salivary glands and do not exclude autoreactive B cells. J Immunol 182(6):3540\u20133547","journal-title":"J Immunol"},{"issue":"4","key":"7748_CR15","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.semarthrit.2012.07.003","volume":"42","author":"AP Risselada","year":"2013","unstructured":"Risselada AP (2013) The role of ectopic germinal centers in the immunopathology of primary Sj\u00f6gren\u2019s syndrome: a systematic review. Semin Arthritis Rheum 42(4):368\u2013376","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"7748_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/1756-185X.12856","volume":"20","author":"J He","year":"2017","unstructured":"He J et al (2017) Characteristics of germinal center-like structures in patients with Sj\u00f6gren\u2019s syndrome. Int J Rheum Dis 20(2):245\u2013251","journal-title":"Int J Rheum Dis"},{"key":"7748_CR17","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1002\/art.38586","volume":"66","author":"X Zhang","year":"2014","unstructured":"Zhang X, He J, Li ZG (2014) Ultrasonographic evaluation of major salivary glands in primary Sj\u00f6gren\u2019s syndrome: comparison of two scoring systems and diagnostic value of sonoelastography. Arthritis Rheumatol 66:S63\u2013S64","journal-title":"Arthritis Rheumatol"},{"key":"7748_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02689-3","author":"X Zhang","year":"2021","unstructured":"Zhang X et al (2021) Salivary gland ultrasonography in primary Sj\u00f6gren\u2019s syndrome from diagnosis to clinical stratification: a multicentre study. Arthritis Res Ther. https:\/\/doi.org\/10.1186\/s13075-021-02689-3","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"7748_CR19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1136\/annrheumdis-2017-212268","volume":"77","author":"BA Fisher","year":"2018","unstructured":"Fisher BA et al (2018) Effect of rituximab on a salivary gland ultrasound score in primary Sj\u00f6gren\u2019s syndrome: results of the TRACTISS randomised double-blind multicentre substudy. Ann Rheum Dis 77(3):412\u2013416","journal-title":"Ann Rheum Dis"},{"key":"7748_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23472-7","author":"P Soret","year":"2021","unstructured":"Soret P (2021) A new molecular classification to drive precision treatment strategies in primary Sj\u00f6gren\u2019s syndrome. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-021-23472-7","journal-title":"Nat Commun"},{"key":"7748_CR21","unstructured":"Lundtoft, C., et al., Complement"},{"key":"7748_CR22","doi-asserted-by":"crossref","unstructured":"copy number variation is linked to SSA\/Ro and SSB\/La autoantibodies in systemic inflammatory autoimmune diseases. Arthritis & Rheumatology, 2022. 74(8): p. 1440\u20131450.","DOI":"10.1002\/art.42122"},{"issue":"8","key":"7748_CR23","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/intimm\/dxab025","volume":"33","author":"S Shimoyama","year":"2021","unstructured":"Shimoyama S et al (2021) Sj\u00f6gren\u2019s syndrome-associated SNPs increase GTF2I expression in salivary gland cells to enhance inflammation development. Int Immunol 33(8):423\u2013434","journal-title":"Int Immunol"},{"issue":"3","key":"7748_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/acr2.11362","volume":"4","author":"EA Gebreegziabher","year":"2022","unstructured":"Gebreegziabher EA (2022) Associations between smoking and primary Sj\u00f6gren syndrome classification using the Sj\u00f6gren\u2019s international collaborative clinical alliance cohort. ACR Open Rheumatol 4(3):231\u2013237","journal-title":"ACR Open Rheumatol"},{"issue":"5","key":"7748_CR25","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41584-023-00932-6","volume":"19","author":"GE Thorlacius","year":"2023","unstructured":"Thorlacius GE, Bj\u00f6rk A, Wahren-Herlenius M (2023) Genetics and epigenetics of primary Sj\u00f6gren syndrome: implications for future therapies. Nat Rev Rheumatol 19(5):288\u2013306","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"7748_CR26","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1002\/jdd.13290","volume":"87","author":"KF Molena","year":"2023","unstructured":"Molena KF (2023) Knowledge changes after applying evidence-based dentistry educational interventions to dental students: a systematic review. J Dent Educ 87(9):1321\u20131369","journal-title":"J Dent Educ"},{"issue":"8","key":"7748_CR27","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41584-021-00634-x","volume":"17","author":"R Seror","year":"2021","unstructured":"Seror R, Nocturne G, Mariette X (2021) Current and future therapies for primary Sj\u00f6gren syndrome. Nat Rev Rheumatol 17(8):475\u2013486","journal-title":"Nat Rev Rheumatol"},{"key":"7748_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22137231","author":"J Kim","year":"2021","unstructured":"Kim J, Kim YS, Park SH (2021) Metformin as a treatment strategy for Sj\u00f6gren\u2019s syndrome. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22137231","journal-title":"Int J Mol Sci"},{"key":"7748_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1904-0","author":"JW Kim","year":"2019","unstructured":"Kim JW (2019) Metformin improves salivary gland inflammation and hypofunction in murine Sj\u00f6gren\u2019s syndrome. Arthritis Res Ther. https:\/\/doi.org\/10.1186\/s13075-019-1904-0","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"7748_CR30","first-page":"2249","volume":"54","author":"S De Vita","year":"2015","unstructured":"De Vita S et al (2015) Efficacy and safety of belimumab given for 12 months in primary Sj\u00f6gren\u2019s syndrome: the BELISS open-label phase II study. Rheumatology 54(12):2249\u20132256","journal-title":"Rheumatology"},{"issue":"12","key":"7748_CR31","doi-asserted-by":"publisher","first-page":"4797","DOI":"10.1093\/rheumatology\/keac167","volume":"61","author":"E Price","year":"2022","unstructured":"Price E (2022) Safety and efficacy of filgotinib, lanraplenib and tirabrutinib in Sj\u00f6gren\u2019s syndrome: a randomized, phase 2, double-blind, placebo-controlled study. Rheumatology 61(12):4797\u20134808","journal-title":"Rheumatology"},{"key":"7748_CR32","doi-asserted-by":"crossref","unstructured":"M\u00fceller-Jensen, L., et al., Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events. Frontiers in Immunology, 2023. 14.","DOI":"10.3389\/fimmu.2023.1108116"},{"key":"7748_CR33","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1136\/annrheumdis-2019-eular.8046","volume":"78","author":"J Tarn","year":"2019","unstructured":"Tarn J et al (2019) The effects of non-invasive vagus nerve stimulationon fatigue and neurocognition in participants with primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis 78:1553\u20131553","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"7748_CR34","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1136\/ard-2023-225445","volume":"83","author":"T Baker","year":"2024","unstructured":"Baker T (2024) Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials. Ann Rheum Dis 83(8):1018\u20131027","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"7748_CR35","first-page":"S142","volume":"38","author":"J Chen","year":"2020","unstructured":"Chen J et al (2020) Evaluation of soluble CD25 as a clinical and autoimmune biomarker in primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol 38(4):S142\u2013S149","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"7748_CR36","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/art.42772","volume":"76","author":"E Pontarini","year":"2024","unstructured":"Pontarini E (2024) Serum and tissue biomarkers associated with compositeof relevant endpoints for Sj\u00f6gren syndrome (CRESS) and Sj\u00f6gren tool for assessing response (STAR) to B cell-targeted therapy in the trial of anti-B cell therapy inpatients with primary Sj\u00f6gren syndrome (TRACTISS). Arthritis Rheumatol 76(5):763\u2013776","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"7748_CR37","first-page":"2437","volume":"42","author":"Q Liu","year":"2024","unstructured":"Liu Q, Xing X, He J (2024) Tofacitinib alleviated salivary gland inflammation and reduced the percentages of effector T cells in murine Sj\u00f6gren\u2019s disease. Clin Exp Rheumatol 42(12):2437\u20132443","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"7748_CR38","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2013-204615","volume":"74","author":"R Seror","year":"2015","unstructured":"Seror R (2015) Validation of EULAR primary Sj\u00f6gren\u2019s syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Ann Rheum Dis 74(5):859\u2013866","journal-title":"Ann Rheum Dis"},{"key":"7748_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(24)00059-6","author":"WJ Zeng","year":"2024","unstructured":"Zeng WJ (2024) The Florida scoring system for stratifying children with suspected Sj\u00f6gren\u2019s disease: a cross-sectional machine learning study. Lancet Rheumatol. https:\/\/doi.org\/10.1016\/S2665-9913(24)00059-6","journal-title":"Lancet Rheumatol"},{"key":"7748_CR40","unstructured":"Gordon, R.A., et al., The Sjo<spacing diaeresis>gren\u2019s working group: the 2023 OMERACT meeting and provisional domain generation. Seminars in Arthritis and Rheumatism, 2024. 65."},{"key":"7748_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152473","author":"D Rebel","year":"2024","unstructured":"Rebel D (2024) Added value of the salivary gland ultrasonography OMERACT score in the ACR\/EULAR classification criteria for Sj\u00f6gren\u2019s disease. Semin Arthritis Rheum. https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152473","journal-title":"Semin Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07748-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07748-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07748-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T12:13:32Z","timestamp":1762776812000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07748-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,18]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["7748"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07748-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,18]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}